Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

Carvedilol - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for carvedilol and what is the scope of patent protection?

Carvedilol is the generic ingredient in four branded drugs marketed by Aurobindo Pharma, Beximco Usa, Chartwell Molecular, Dr Reddys Labs Ltd, Glenmark Generics, Hikma, Lupin, Mylan, Pliva Hrvatska Doo, Rubicon, Sandoz, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Taro, Teva, Wockhardt Ltd, Zydus Pharms Usa Inc, Smithkline Beecham, Impax Labs Inc, and Sun Pharm Industries, and is included in twenty-one NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-seven drug master file entries for carvedilol. Forty-five suppliers are listed for this compound.

Summary for carvedilol

US Patents:	2
Tradenames:	4
Applicants:	20
NDAs:	21
Drug Master File Entries:	37
Suppliers / Packagers:	45
Bulk Api Vendors:	106
Clinical Trials:	150
Patent Applications:	5,758
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for carvedilol
Drug Sales Revenues:	Drug sales revenues for carvedilol
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for carvedilol
DailyMed Link:	carvedilol at DailyMed

See drug prices for carvedilol

Drug Sales Revenue Trends for carvedilol

See drug sales revenues for carvedilol

Recent Clinical Trials for carvedilol

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Abramson Cancer Center of the University of Pennsylvania	Phase 1
Fundação de Amparo à Pesquisa do Estado de São Paulo	Phase 4
NovoCure Ltd.	Early Phase 1

See all carvedilol clinical trials

Recent Litigation for carvedilol

Identify potential future generic entrants

District Court Litigation

Case Name	Date
GlaxoSmithKline LLC v. Teva Pharmaceuticals USA Inc.	2014-07-03
GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA	2014-07-03
TEVA PHARMACEUTICAL INDUSTRIES LTD. v. APOTEX, INC.	2007-11-15

See all carvedilol litigation

Pharmacology for carvedilol

Drug Class	alpha-Adrenergic Blocker beta-Adrenergic Blocker
Mechanism of Action	Adrenergic alpha-Antagonists Adrenergic beta1-Antagonists Adrenergic beta2-Antagonists

Synonyms for carvedilol

(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol
[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine
1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol
102641-EP2270011A1
102641-EP2272841A1
102641-EP2275420A1
102641-EP2298764A1
102641-EP2298765A1
102641-EP2301936A1
107741-96-8
2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, (+-)-
72956-09-3
956C093
AB0008431
AB00639903_10
AB00639903_11
AB00639903_12
AB00639903-07
AB00639903-09
AB1004830
AC-1641
AC1L1E0B
AKOS005554967
AN-14749
API0001873
Artist
Artist (TN)
AX8120145
BBL029064
BC204100
BCP0726000253
BCP23386
BCP9000493
BDBM25759
BG0129
BM 14.190
BM 14190
BM-14-190
BM-14.190
BM-14190
BRD-A10977446-001-04-8
BRD-A10977446-001-05-5
BRD-A10977446-045-01-1
C-21835
C06875
C24H26N2O4
Carvedilol (JAN/USAN/INN)
Carvedilol [USAN:INN:BAN:JAN]
Carvedilol [USAN:USP:INN:BAN:JAN]
Carvedilol 1.0 mg/ml in Methanol
Carvedilol for system suitability, European Pharmacopoeia (EP) Reference Standard
Carvedilol, >=98% (HPLC), solid
Carvedilol, European Pharmacopoeia (EP) Reference Standard
Carvedilol, Pharmaceutical Secondary Standard; Certified Reference Material
Carvedilol, United States Pharmacopeia (USP) Reference Standard
Carvedilolum
Carvedilolum [Latin]
CC-25436
CCG-100917
CCG-207952
CHEBI:3441
CHEMBL723
Coreg
Coreg (TN)
Coreg CR
Coropress
CPD000449280
CS-1194
CTK3J2232
D00255
DB01136
Dibloc
Dilatrend
DQ 2466
DQ-2466
DTXSID8022747
EG-P042
Eucardic
FT-0603059
FT-0652640
GTPL551
HMS2051N03
HMS2089B09
HMS2093E12
HMS3261E15
HMS3269N11
HMS3393N03
HMS3655O14
HMS3715D15
HSDB 7044
HY-B0006
I06-0064
I06-1477
J10039
KB-75594
KBio2_002145
KBio2_004713
KBio2_007281
KBio3_002323
KBioGR_001252
KBioSS_002145
Kredex
KS-00000XRT
KS-1037
KSC492E3F
L001243
LP00347
LS-121875
MCULE-7944987271
MFCD00864692
MLS000758299
MLS000759508
MLS001424092
MLS006011886
MolPort-003-666-814
NC00167
NCGC00167832-01
NCGC00167832-02
NCGC00167832-03
NCGC00167832-04
NCGC00261032-01
NSC-758694
NSC758694
OGHNVEJMJSYVRP-UHFFFAOYSA-N
Pharmakon1600-01504257
PubChem18218
Q-200801
Querto
RTR-037608
s1831
SAM001246736
SAM001247021
SB17441
SBI-0206771.P001
SC-13445
SCHEMBL10082334
SCHEMBL13287211
SCHEMBL22293
SK&F-105517
SKF 105517
SMR000449280
SPBio_001885
Spectrum_001665
Spectrum2_001673
Spectrum3_001182
Spectrum4_000636
Spectrum5_001436
SR-01000759289
SR-01000759289-5
SR-01000759289-6
SR-01000759289-9
ST24036957
STK621453
SW197547-3
TL8005080
Tox21_500347
TR-037608
W-5131
Z2786051695

US Patents and Regulatory Information for carvedilol

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Request a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wockhardt Ltd	CARVEDILOL	carvedilol	TABLET;ORAL	078786-003	Dec 22, 2009		DISCN	No	No	See Pricing	See Pricing				See Pricing
Smithkline Beecham	COREG	carvedilol	TABLET;ORAL	020297-003	Sep 14, 1995	AB	RX	Yes	No	See Pricing	See Pricing				See Pricing
Wockhardt Ltd	CARVEDILOL	carvedilol	TABLET;ORAL	078786-004	Dec 22, 2009		DISCN	No	No	See Pricing	See Pricing				See Pricing
Smithkline Beecham	COREG	carvedilol	TABLET;ORAL	020297-001	Sep 14, 1995	AB	RX	Yes	No	See Pricing	See Pricing				See Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for carvedilol

Subscribe to access the full database, or Request a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Smithkline Beecham	COREG	carvedilol	TABLET;ORAL	020297-003	Sep 14, 1995	See Pricing	See Pricing
Smithkline Beecham	COREG	carvedilol	TABLET;ORAL	020297-001	Sep 14, 1995	See Pricing	See Pricing
Smithkline Beecham	COREG	carvedilol	TABLET;ORAL	020297-001	Sep 14, 1995	See Pricing	See Pricing
Smithkline Beecham	COREG	carvedilol	TABLET;ORAL	020297-004	May 29, 1997	See Pricing	See Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.